{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:39:32Z","timestamp":1755225572326,"version":"3.43.0"},"reference-count":26,"publisher":"BMJ","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J R Army Med Corps"],"accepted":{"date-parts":[[2013,2,1]]},"published-print":{"date-parts":[[2013,9]]},"abstract":"<jats:p>We describe the case of a British soldier, originally from southeast Africa, who presented to the British military hospital in Helmand Province, southern Afghanistan, with a history of constitutional upset, profound anaemia and diffuse lymphadenopathy with hepatosplenomegaly. Following evacuation to the UK investigations revealed a rare (and a not so rare) diagnosis. This case raises a number of questions regarding the population at risk, the prevalence of endemic diseases in this population and laboratory capabilities in the deployed setting.<\/jats:p>","DOI":"10.1136\/jramc-2013-000040","type":"journal-article","created":{"date-parts":[[2013,3,23]],"date-time":"2013-03-23T20:13:05Z","timestamp":1364069585000},"page":"243-246","source":"Crossref","is-referenced-by-count":0,"title":["An unusual case of anaemia and lymphadenopathy in a soldier on deployment"],"prefix":"10.1136","volume":"159","author":[{"given":"M K","family":"O'Shea","sequence":"first","affiliation":[{"name":"ST5 Infectious Diseases and Tropical Medicine, Heartlands Hospital and Royal Centre for Defence Medicine, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Gregg","sequence":"additional","affiliation":[{"name":"ST5 Haematology, Queen Elizabeth Hospital, Edgbaston, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Naylor","sequence":"additional","affiliation":[{"name":"MDHU Peterborough, Peterborough City Hospital, Edith Cavell Campus, Peterborough, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2013,3,22]]},"reference":[{"key":"2025081306440080000_159.3.243.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM195406102502308"},{"key":"2025081306440080000_159.3.243.2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(195607\/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4"},{"key":"2025081306440080000_159.3.243.3","first-page":"3","article-title":"Castleman's disease. A review","volume":"11","author":"Roca","year":"2009","journal-title":"AIDS Rev"},{"key":"2025081306440080000_159.3.243.4","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197203)29:3<670::AID-CNCR2820290321>3.0.CO;2-#"},{"key":"2025081306440080000_159.3.243.5","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<706::AID-CNCR21>3.0.CO;2-7"},{"key":"2025081306440080000_159.3.243.6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1081\/CNV-50484","article-title":"Complete remission with anti-CD20 therapy for unicentric, non-HIV-associated, hyaline-vascular type, Castleman's disease","volume":"23","author":"Estephan","year":"2005","journal-title":"Cancer Invest"},{"key":"2025081306440080000_159.3.243.7","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010801)92:3<670::AID-CNCR1369>3.0.CO;2-Q"},{"key":"2025081306440080000_159.3.243.8","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn697"},{"key":"2025081306440080000_159.3.243.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199505043321801"},{"key":"2025081306440080000_159.3.243.10","doi-asserted-by":"publisher","DOI":"10.1126\/science.7997879"},{"key":"2025081306440080000_159.3.243.11","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1182\/blood.V86.4.1276.bloodjournal8641276","article-title":"Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease","volume":"86","author":"Soulier","year":"1995","journal-title":"Blood"},{"key":"2025081306440080000_159.3.243.12","first-page":"798","article-title":"Herpes-like DNA sequences, AIDS-related tumors, and Castleman's disease","volume":"333","author":"Dupin","year":"1995","journal-title":"N Engl J Med"},{"key":"2025081306440080000_159.3.243.13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04120.x"},{"key":"2025081306440080000_159.3.243.14","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1182\/blood.V95.4.1406.004k26_1406_1412","article-title":"HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma","volume":"95","author":"Dupin","year":"2000","journal-title":"Blood"},{"key":"2025081306440080000_159.3.243.15","first-page":"636","article-title":"Multicentric Castleman's disease","volume":"20","author":"Peterson","year":"1993","journal-title":"Semin Oncol"},{"key":"2025081306440080000_159.3.243.16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.34.1909"},{"key":"2025081306440080000_159.3.243.17","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-12-200712180-00003"},{"key":"2025081306440080000_159.3.243.18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-290213"},{"key":"2025081306440080000_159.3.243.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199906173402415"},{"key":"2025081306440080000_159.3.243.20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-333633"},{"key":"2025081306440080000_159.3.243.21","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21108"},{"key":"2025081306440080000_159.3.243.22","doi-asserted-by":"publisher","DOI":"10.1002\/1096-8652(200102)66:2<148::AID-AJH1034>3.0.CO;2-P"},{"key":"2025081306440080000_159.3.243.23","first-page":"25","article-title":"Multicentric Castleman's disease in HIV infection: a systematic review of the literature","volume":"10","author":"Mylona","year":"2008","journal-title":"AIDS Rev"},{"key":"2025081306440080000_159.3.243.24","unstructured":"The national strategy for sexual health and HIV. Sexual health and HIV Strategy Integrated Steering Group United Kingdom. London: PHLS, 2001."},{"key":"2025081306440080000_159.3.243.25","unstructured":"UK National Guidelines for HIV testing 2008 http:\/\/www.bhiva.org\/documents\/Guidelines\/Testing\/GlinesHIVTest08.pdf (accessed 4 June 2012)."},{"key":"2025081306440080000_159.3.243.26","unstructured":"BASHH Clinical Governance Committee Guidance on the appropriate use of HIV point of care tests. http:\/\/www.bashh.org\/documents\/1176\/1176.pdf (accessed 4 June 2012)."}],"container-title":["Journal of the Royal Army Medical Corps"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jramc-2013-000040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T13:44:10Z","timestamp":1755092650000},"score":1,"resource":{"primary":{"URL":"https:\/\/militaryhealth.bmj.com\/lookup\/doi\/10.1136\/jramc-2013-000040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,22]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,8,7]]},"published-print":{"date-parts":[[2013,9]]}},"alternative-id":["10.1136\/jramc-2013-000040"],"URL":"https:\/\/doi.org\/10.1136\/jramc-2013-000040","relation":{},"ISSN":["0035-8665","2052-0468"],"issn-type":[{"type":"print","value":"0035-8665"},{"type":"electronic","value":"2052-0468"}],"subject":[],"published":{"date-parts":[[2013,3,22]]}}}